KHRNF Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.09
Previous CloseN/A
Volume20.00K
Average Volume (3M)N/A
Market Cap
$5.07M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding229,514,920
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KHRNF FAQ
What was Khiron Life Sciences Corp’s price range in the past 12 months?
Khiron Life Sciences Corp lowest stock price was <$0.01 and its highest was $0.09 in the past 12 months.
What is Khiron Life Sciences Corp’s market cap?
Khiron Life Sciences Corp’s market cap is $5.07M.
When is Khiron Life Sciences Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Khiron Life Sciences Corp’s earnings last quarter?
Currently, no data Available
Is Khiron Life Sciences Corp overvalued?
According to Wall Street analysts Khiron Life Sciences Corp’s price is currently Overvalued.
Does Khiron Life Sciences Corp pay dividends?
Khiron Life Sciences Corp does not currently pay dividends.
What is Khiron Life Sciences Corp’s EPS estimate?
Khiron Life Sciences Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Khiron Life Sciences Corp have?
Khiron Life Sciences Corp has 229,514,920 shares outstanding.
What happened to Khiron Life Sciences Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Khiron Life Sciences Corp?
Currently, no hedge funds are holding shares in KHRNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Khiron Life Sciences Corp
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---